Quality assurance of thoracic radiotherapy in EORTC 08941: A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy

European Journal of Cancer

Volumn 42, Issue 10, 2006, Pages 1391-1398

  Kramer, Gijsbert W P M ^a   Legrand, Catherine L ^b   van Schil, Paul ^c   Uitterhoeve, Lon ^d   Smit, Egbert F ^e   Schramel, Franz ^f   Biesma, Bonne ^g   Tjan Heijnen, Vivianne ^h   van Zandwijk, Nico ⁱ   Splinter, Ted ^j   Giaccone, Giuseppe ^e   van Meerbeeck, Jan P ^k  

^a Arnhems Radiotherapeutisch Instituut   (Netherlands)

^b EORTC DATA CENTER   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g JEROEN BOSCH HOSPITAL   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ NETHERLANDS CANCER INSTITUTE   (Netherlands)

^j ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^k GHENT UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

Non small cell lung cancer; Quality assurance; Radiotherapy

Indexed keywords

CISPLATIN; GEMCITABINE; PLATINUM DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; ESOPHAGUS INJURY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PATIENT COMPLIANCE; PHARYNX DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; RANDOMIZATION; STATISTICAL SIGNIFICANCE; THORAX CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PATIENT COMPLIANCE; QUALITY ASSURANCE, HEALTH CARE;

EID: 33745119518     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.01.052     Document Type: Article

References (22)

1. NSCLC Collaborative Group. Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311 (1995) 899-909
2. Marino P., Preatoni A., and Cantoni A. Randomised trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stage IIIa and IIIb non-small-cell lung cancer. A meta-analysis. Cancer 76 (1995) 593-601
3. Pritchard R.S., and Anthony S.P. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med 125 (1996) 23-29
4. Splinter T.A.W., van Schil P., Kramer G.W.P.M., et al. Randomized Trial of Surgery Versus Radiotherapy in Patients with Stage IIIA (N2) Non-Small-Cell Lung Cancer After a Response to Induction Chemotherapy. EORTC 08941. Clin Lung Cancer 2 (2000) 69-72 discussion 73
5. Kouloulias V.E., Poortmans P.M., Bernier J., et al. The Quality Assurance Programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts. Eur J of Cancer 39 (2003) 430-437
6. Schaake-Koning C., Kirkpatrick A., Kroger R., van Zandwijk N., and Bartelink H. The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups. Eur J Cancer 27 (1991) 615-619
7. van Meerbeeck J.P., Kramer G.W.P., Van Schil P.E., et al. A randomised trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small-cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) EORTC 08941. J Clin Oncol. 23 16S (2005) 1095S #7015
8. Bolla M., Bartelink H., Garavaglia G., et al. EORTC guidelines for writing protocols for clinical trials of radiotherapy. Radiother Oncol. 36 (1995) 1-8
9. ICRU Report 50 (1993): Prescribing, Recording and Reporting Photon Beam Therapy. ISBN 0-913394-48-3.
10. Williams J., Chen Y., Rubin P., et al. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 13 (2003) 182-188
11. Perez C.A., Purdy J.A., Harms W., et al. Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation. Radiother Oncol. 36 (1995) 34-43
12. Slotman B.J., and Leer J.W. Infrastructure of radiotherapy in the Netherlands: evaluation of prognoses and introduction of a new model for determining the needs. Radiother Oncol. 66 (2003) 345-349
13. Shih H.A., Jiang S.B., Aljarrah K.M., et al. Internal target volume determined with expansion margins beyond composite gross tumour volume in three-dimensial conformal radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 60 (2004) 613-622
14. van Sörnsen de Koste J.R., Lagerwaard F.J., Schuchhard-Schipper R.H., et al. Dosimetric consequences of tumour mobility in radiotherapy of stage I non-small cell lung cancer - an analysis of data generated using 'slow'CT scans. Radiother Oncol. 61 (2001) 93-99
15. Lagerwaard F.J., van de Vaart P.J., Voet P.W., et al. Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)?. Lung Cancer 38 (2002) 297-301
16. Lester J.F., Macbeth F.R., Brewster A.E., et al. CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small-cell lung cancer. Lung Cancer 45 (2004) 237-242
17. Cheung P.C., Yeung L.T., Basrur V., et al. Accelerated hypofractionation for early-stage non-small-cell cancer. Int J Radiat Oncol Biol Phys. 54 (2003) 1014-1023
18. Saunders M., Dische S., Barrett A., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 350 (1997) 161-165
19. Abratt R.P., Bogart J.A., and Hunter A. Hypofractionated irradiation for non-small cell lung cancer. Lung Cancer 36 (2002) 225-233
20. Joiner M.C., and van der Kogel A.J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel G.G. (Ed). Basic Clinical Radiobiology. 2nd ed. (1977), Edward Arnold, Kent, UK 106-122 Chapter 13
21. Van Zandwijk N., Smit E.F., Kramer G.W.P., et al. Gemcitabine and Cisplatin as Induction Regimen for Patients with Biopsy-Proven Stage IIIA N2 Non-Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol. 18 (2000) 2658-2664
22. Maas K.W., van der Lee I., Bolt K., et al. Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. Lung Cancer 41 (2003) 345-351